Category Archives: Myocardial Infarction

(CNN) -- The US Centers for Disease Control and Prevention warns that some people may be putting off getting emergency care for serious health conditions during the coronavirus pandemic -- and fewer visits for critical conditions could result in complications or even death. During the coronavirus pandemic, the total number of visits to hospital emergency departments across the United States for conditions other than Covid-19 was 42% lower than during this same time last year, according to a new CDC report. The new research, published in the CDC's Morbidity and Mortality Weekly Report on Wednesday, found that emergency department visits drastically fell from about 2.1 million visits per week between March 31 and April 27 last year to 1.2 million between March 29 and April 25 this year. Continue reading →

SHIRLEY, N.Y., June 3, 2020 /PRNewswire/ --American Regent announces the introduction and availability of Estradiol Valerate Injection, USP AO Rated and therapeutically equivalent to Delestrogen1,2. Estradiol Valerate Injection is indicated in the: "We are proud to add Estradiol Valerate Injection to our robust product line of products that are manufactured in America. We are also pleased to provide patients with another treatment option from American Regent," stated Harsher Singh, Vice President, Chief Commercial and Strategic Officer at American Regent, Inc. Continue reading →

Global Post-Myocardial Infarction Market: Overview The most common term used to refer to myocardial infarction is heart-attack. In this report, TMR Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. Continue reading →

Global Myocardial Infarction Drug Market research report offers the important insights regarding the Myocardial Infarction Drug Market in the current scenario. In addition, report consists the future prospects of the Myocardial Infarction Drug by analyzing the various market elements including the current trends, opportunities, restraints, and market drivers. The COVID-19 examination area inside the report offers convenient bits of knowledge with respect to the effect of the worldwide pandemic available. Continue reading →

UpMarketResearch offers a latest published report on Global Myocardial Infarction Drug Market industry analysis and forecast 20192025 delivering key insights and providing a competitive advantage to clients through a detailed report. Continue reading →

The management of cardiovascular risk in patients with diabetes admitted with coronavirus disease 2019 (COVID-19), which has been found to affect multiple organs, including the heart, kidneys, and lungs, should be adapted to this population, according to an article by an international team of diabetes and endocrinology experts published in Diabetes Care. In patients with diabetes, a severe infection with SARS-CoV-2 can cause arrhythmias, myocardial infarction, myocarditis, and heart failure. Continue reading →

An ice cream vendor walks by a mobile health clinic displaying a picture of Nicaragua's President Daniel Ortega (R) and his wife Vice-President Rosario Murillo (R) in Managua on April 14, 2020 during the pandemic of the novel coronavirus COVID-19. ( (Photo by INTI OCON / AFP)) The Nicaraguan government reported on Tuesday a weekly increaseof 359 new coronavirus cases and 11 more deaths, according to a report from the Health Ministry. That brings the official total number of cases to 1,118 and the death toll to 46 both well below independent counts Continue reading →

Arca Biopharma Inc., of Westminster, Colo., is developing AB-201, a selective inhibitor of tissue factor (TF), as a treatment for COVID-19-associated coagulopathy, abnormal blood clotting and related inflammatory response. Continue reading →

New research has found that atherosclerosis can create changes in the heart even in those who are free from heart failure and myocardial infarction. Atherosclerosis, or calcium build-up in the coronary arteries, is a strong predictor of future coronary heart disease. Continue reading →

DANVERS, Mass.--(BUSINESS WIRE)--Jun. 1, 2020-- The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for Impella RP to include patients suffering from COVID-19 related right heart failure or decompensation, including pulmonary embolism (PE) Continue reading →